Therefore, we investigated the associations of XCL1 expression on tumor cells with tumor infiltration of CD8-positive T cells and PD-L1 expression on tumor cells, which is known as a biomarker for immune checkpoint inhibitors [28]. This evidence concerns the gene CD8A and neoplasm.